Literature DB >> 23380184

Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization.

Antonio La Marca1, Giovanna Sighinolfi, Cindy Argento, Valentina Grisendi, Livio Casarini, Annibale Volpe, Manuela Simoni.   

Abstract

Since gonadotropins are the fundamental hormones that control ovarian activity, genetic polymorphisms may alter gonadal responsiveness to glycoproteins; hence they are important regulators of hormone activity at the target level. The establishment of the pool of primordial follicles takes place during fetal life and is mainly under genetic control. Consequently, single nucleotide polymorphisms (SNPs) in gonadotropins and their receptors do not seem to be associated with any significant modification in the endowment of nongrowing follicles in the ovary. Indeed, the age at menopause, a biological characteristic strongly related to ovarian reserve, as well as markers of functional ovarian reserve such as anti-Müllerian hormone and antral follicle count, are not different in women with different genetic variants. Conversely, some polymorphisms in FSH receptor (FSHR) seem to be associated with modifications in ovarian activity. In particular, studies suggest that the Ser680 genotype for FSHR is a factor of relative resistance to FSH stimulation resulting in slightly higher FSH serum levels, thus leading to a prolonged duration of the menstrual cycle. Moreover, some FSHR gene polymorphisms show a positive association with ovarian response to exogenous gonadotropin administration, hence exhibiting some potential for a pharmacogenetic estimation of the FSH dosage in controlled ovarian stimulation. The study of SNPs of the FSHR gene is an interesting field of research that could provide us with new information about the way each woman responds to exogenous gonadotropin administration during ovulation induction.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380184     DOI: 10.1016/j.fertnstert.2013.01.086

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

1.  Implications of Blood Type for Ovarian Reserve and Infertility - Impact on Oocyte Yield in IVF Patients.

Authors:  D Spitzer; C Corn; J Stadler; B Wirleitner; M Schuff; P Vanderzwalmen; F Grabher; N H Zech
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-10       Impact factor: 2.915

2.  LH (Trp8Arg/Ile15Thr), LHR (insLQ) and FSHR (Asn680Ser) polymorphisms genotypic prevalence in women with endometriosis and infertility.

Authors:  Carla Regina Schmitz; Carlos Augusto Bastos de Souza; Vanessa Krebs Genro; Ursula Matte; Emily de Conto; João Sabino Cunha-Filho
Journal:  J Assist Reprod Genet       Date:  2015-05-03       Impact factor: 3.412

3.  Ovarian biomarkers predict controlled ovarian stimulation for in vitro fertilisation treatment in Singapore.

Authors:  Ryan Wai Kheong Lee; Lay Wai Khin; Marianne Sybille Hendricks; Heng Hao Tan; Sadhana Nadarajah; Nancy Wen Sim Tee; Seong-Feei Loh; Bee Choo Tai; Jerry Ky Chan
Journal:  Singapore Med J       Date:  2020-09       Impact factor: 1.858

4.  The carriers of the A/G-G/G allelic combination of the c.2039 A>G and c.-29 G>A FSH receptor polymorphisms retrieve the highest number of oocytes in IVF/ICSI cycles.

Authors:  Adolfo Allegra; Angelo Marino; Stefania Raimondo; Antonio Maiorana; Salvatore Gullo; Piero Scaglione; Aldo Volpes; Riccardo Alessandro
Journal:  J Assist Reprod Genet       Date:  2016-11-05       Impact factor: 3.412

5.  Are There Ovarian Responsive Indexes That Predict Cumulative Live Birth Rates in Women over 39 Years?

Authors:  Sara Cesarano; Paul Pirtea; Achraf Benammar; Dominique De Ziegler; Marine Poulain; Alberto Revelli; Chiara Benedetto; Alexandre Vallée; Jean Marc Ayoubi
Journal:  J Clin Med       Date:  2022-04-08       Impact factor: 4.964

Review 6.  Genomic markers of ovarian reserve.

Authors:  Michelle A Wood; Aleksandar Rajkovic
Journal:  Semin Reprod Med       Date:  2013-10-07       Impact factor: 1.303

7.  Genotyping common FSHR polymorphisms based on competitive amplification of differentially melting amplicons (CADMA).

Authors:  Tanni Borgbo; Lasse Sommer Kristensen; Ida Lindgren; Claus Yding Andersen; Lise Lotte Hansen
Journal:  J Assist Reprod Genet       Date:  2014-09-21       Impact factor: 3.412

8.  Association between age at menopause and fracture risk: a systematic review and meta-analysis.

Authors:  Panagiotis Anagnostis; Pavlos Siolos; Nifon K Gkekas; Nikoletta Kosmidou; Aikaterini-Maria Artzouchaltzi; Konstantinos Christou; Stavroula A Paschou; Michael Potoupnis; Eustathios Kenanidis; Eleftherios Tsiridis; Irene Lambrinoudaki; John C Stevenson; Dimitrios G Goulis
Journal:  Endocrine       Date:  2018-09-10       Impact factor: 3.633

9.  Reduced FSH and LH action: implications for medically assisted reproduction.

Authors:  E Bosch; C Alviggi; M Lispi; A Conforti; A C Hanyaloglu; D Chuderland; M Simoni; N Raine-Fenning; P Crépieux; S Kol; V Rochira; T D'Hooghe; P Humaidan
Journal:  Hum Reprod       Date:  2021-05-17       Impact factor: 6.918

10.  Evaluating influence of the genotypes in the follicle-stimulating hormone receptor (FSHR) Ser680Asn (rs6166) polymorphism on poor and hyper-responders to ovarian stimulation: a meta-analysis.

Authors:  Noel Pabalan; Camila Martins Trevisan; Carla Peluso; Hamdi Jarjanazi; Denise Maria Christofolini; Caio Parente Barbosa; Bianca Bianco
Journal:  J Ovarian Res       Date:  2014-12-20       Impact factor: 4.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.